contact@tendernotify.co.uk
Back to suppliers

Teva UK Limited

Total awarded
£1,648,511,005
NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
15 Jun 2026 £166,347,397
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026
01 Jun 2026 £813,863,584
NHS National Generics Pharmaceuticals - Supply Chain Resilience
01 May 2026 £35,010,320
NHS National Branded Interim - 1 June 2026
10 Apr 2026 £529,090,780
NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide
24 Mar 2026 £19,595,208
NHS National Generic Pharmaceuticals - Wave 15c
13 Jan 2026 £37,160,000
NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin
25 Nov 2025 £25,881,000
NHS National Framework for Generics Housekeeping
10 Nov 2025 £21,562,716
NP36126 Antibiotic & Genito Urinary Medicines
NHS National Framework for Denosumab Injection commencing 1st January 2026
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025
NHS National Framework for Transition products (Axitinib and Eltrombopag)